Liver damage induced by drugs is the main cause of acute liver failure in Europe and the United States. Its severity and evolution are highly variable, depend on the affected individual and is not easy to predict. Read More
This open code equipment, which can be manufactured and programmed for free anywhere in the world, was designed by Spanish researchers during the first wave of the pandemic. Read More
Selene Valero and José Gil, researchers at the Faculty of Psychology and Speech Therapy of the University of Valencia, have studied the changes in sleep behaviour and emotional stability of healthy patients and with previous pathologies before and after the COVID-19 pandemic.
The research group Immunology of Fungal Infections at the University of Valencia (UV) has investigated a fungal vaccine with which to train stem cells and hematopoietic progenitors (which produce all the cells of the blood and lifelong immune system) to improve the immune response to infections. The work has been published in the journal Frontiers in Immunology.
Male, with low levels of consciousness and kindness and with high school maladjustment is the majority profile among young people with this type of addiction. Read More
Different institutions, including the University of Valencia (UV), have studied the relationship between sarcopenia (loss of muscle mass in older people) and obesity derived from this condition with a lack of protein in the diet of women over 65 years of age. 164 Valencian women participated in the study, published in the journal Nutrición Hospitalaria.
The CovidLap study was made possible thanks to the solidarity of donations from individuals and organisations during the #SomUJIcontraCOVID campaign. Read More
Professor and researcher of the Faculty of Nursing and Podiatry of the UV, Yasmín Ezzatvar, together with researchers from other centres, concludes that the racial or ethnic group of patients with type 1 and 2 diabetes mellitus influences the prognosis of the disease, due to differences in mortality, risk of kidney disease or risk of cardiovascular disease. In their research, they analysed data from 2,416,516 diagnosed people. This is the first study to quantify these differences.
The University of Valencia and the Biotechvana company of its Science Park have participated in the development and validation of a new pandemic simulator that helps predict their evolution in different epidemiological scenarios. The system, called LOIMOS, has been developed in the context of COVID-19 and its results are limited to the SARS-CoV-2 virus, although they could be applied to the study of other pandemics. The work is published in journal microLife.